By Li, J-Y; Li, X-Y; Li, M; Zhang, G-K; Et al
Abstract
Objective. To investigate the age-related change of serum androgen levels in healthy men and to define a cut-off value of serum testosterone for the diagnosis of androgen deficiency in the aging male.
Method. 1080 healthy men aged 20 to ≥70 years old were enrolled in Beijing, Shanghai, Xian and Chongqing. Luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone (T), calculated free testosterone (cFT), sex hormone binding globulin (SHBG), 17beta-oestradiol (E2), the T/LH ratio, and T/SHBG as a free testosterone index (FTI) were all determined.
Results. Serum total T did not significantly decline, but the cFT, T/LH and FTI progressively decreased with aging. To determine androgen deficiency, the 10th percentile value of men 70 years.
Conclusions. (i). While serum total T values do not decline with aging, the levels of cFT gradually decline with aging; (ii) when using the value of cFT of the 10th percentile of men aged 20 to 39 years as the cut-off point, the prevalence of androgen deficiency was
Keywords: Calculated free testosterone, T/LH, aging men
Introduction
In 1940s, Werner was the first to describe a climacteric-like syndrome in men, with symptoms of sexual dysfunction, loss of libido, palpitations, flushing, episodic sweating, loss of energy, depression, and mood swings [1]. Over the past two decades a large number of studies have documented that serum total testosterone decline with aging-particularly free, nonbound testosterone and bio- available testosteronewhile the serum level of sex hormone binding globulin (SHBG) increase with aging [2-6]. Almost all commentaries dismiss the concept of a male menopause or andropause, but rather describe partial androgen deficiency in the aging male (PADAM) [5- 7] or late onset hypogonadism (LOH) [8]. It still remains a point of debate how to define the criteria for testosterone deficiency in elderly men [8-10]. Age-appropriate reference values are lacking; therefore, it has been proposed that the same criteria as for the general male population be used [11]. We conducted a large-scale study of 1080 healthy adult men, aged 20 years and above, in four major cities in China (Beijing, Shanghai, Xian and Chongqing), between December 2002 and December 2003. Depending on this database, the cut-off point for definition of androgen deficiency was set to be the 10th percentile value of men aged 20 to 39 years. We did not observe a decline of serum total testosterone with aging, but in conformity with studies in other parts of the world, there was a progressive decrease of free testosterone levels [2-6].
Subjects and methods
Subjects. Two hundred and seventy subjects were enrolled from each of the following four citiesBeijing, Shanghai, Xian and Chongqing-in China. These subjects were divided in nine subgroups, each comprising 30 subjects, based on age, the categories being: 20- 29, 30-39, 40-49, 50-54, 55-59, 60-64, 65-69, 70-74, and ≥70 years old. Written informed consent was obtained from each participant. Men had to be aged ≥20 years old to participate in this study. Subjects could only be included in this study if there was: (i) no acute systemic disease; (ii) normal functions of heart, liver, and kidney; (iii) no diabetes or other endocrine disease; (iv) no drug addiction; and (v) if they were living independently (not institutionalized).
Anthropometric and hormone measurements. The history of diseases and medication was taken for each subject, and a physical examination performed, with body mass index (BMI, kg/m2), and waist- hip ratio (WHR, cm/cm) being measured. A peripheral blood sample was drawn between 07:30 h to 08:30 h on the morning following the examination, and serum was kept in – 80C until hormone determination.
Luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone (T), and 17betaoestradiol (E2) were determined by Automated Chemiluminescence System (ACS: 180, Bayer) with intra- assay CVs of 4.8%, 3.0%, 6.5%, and 8.3% , respectively, and inter- assay CVs of 6.6%, 4.6%, 7.0%, and 8.6%, respectively. SHBG measurement was performed by ILISA (IBL, Hamburg). The intraassay CV was 5.5%, and the inter-assay CV was 9.0%. The free testosterone (cFT) was calculated using the formula developed by Vermeulen et al. [12], which has been considered to be a reliable method [9]. We further calculated the ratio of T (nmol/L) to LH (IU/L), and the free testosterone index (FTI) to be the ratio of T (nmol/L) to SHBG (nmol/L).
Statistical analysis. The serum androgen values were not normally distributed; therefore percentiles were used for statistical analysis. The 10th percentile value of androgen at age less than 40 years was arbitrarily set to be the cut-off point of androgen deficiency.
As there was no significant difference between hormone measurements in men aged 40 to 49 years and those from the younger group (20-39 years), they were grouped together. Men over 50 years old were regrouped by 10-year intervals. The KruskallWallis test was used to compare differences in hormone levels between age groups, and ANOVA was used to determine prevalence of androgen deficiency, which we defined in this study as being values lying below the 10th percentile of the values obtained from participating males under 39 years.
Table I. Age-related change of serum sex hormones expressed by median (n).
Results
The serum hormone levels, expressed as median values for each age subgroup (in decades), are presented in Table I. The serum level of total T did not change significantly with aging. However, the values for cFT, T/LH ratio (TSI), and FTI significantly decreased with aging, whereas this trend was weak for the ratio of T/E2. By contrast, LH, FSH, SHBG and E2 serum levels increased with aging. Spearman’s analysis (Table II) showed a negative correlation between cFT, T/LH or FTI with age, and with serum levels of LH or FSH.
The 10th and 90th percentile values of T, cFT, TSI, and FTI are shown in Table III. The 10th percentile value of the results of men aged 20 to 39 years were grouped together and were subsequently considered to be the lower limit of normal values for men below middle age. On the basis of this calculation, the lower cut-off value for cFT to define androgen deficiency was 0.3 nmol/L, 2.8 nmol/ IU for TSI, and 0.4 nmol/IU for FTI. For the purpose of this study, the percentage of men (in each age category) with levels above and below this cut-off point of cFT, TSI, and FTI are presented in Table IV. The cFT serum level started to decrease in a small number of men in their fifth decade, and became more profound with aging. The prevalence of androgen deficiency is presented in Table V. Using cFT as a criterion, 13% of adult men showed androgen deficiency between 40 to 49 years, approximately 30% between the ages of 50 to 69 years, and about 45% in those men over 70 years.
Discussion
An age-related decline of serum total testosterone, and particularly serum free- or bio-available testosterone, has been reported by a number of cross sectional and longitudinal studies [2- 6]. Our data fail to illustrate a decline in serum total testosterone with male aging, but do reflect previous findings regarding the decline of serum cFT in healthy men, with a progressive increase of serum SHBG levels with aging [13]. FT or bio- available T is the proportion of circulating T not bound to SHBG or albumin, respectively, and is regarded as the physiologically active fraction of total testosterone [12]. The etiology of the decline of serum T with aging is partly the result of testicular failure, and partly a result of diminished stimulation of the Leydig cell by decreased output of LH [6]. We did not find serum total T to decline with aging, but serum LH levels rose significantly with aging. This is most likely an expression to a certain extent of a compensated testicular failure with aging [14], which sometimes fails [14], but probably not in the sample of men we studied, as evidenced by their stable serum total T levels with aging. The maintenance of relatively stable total T levels with aging is probably largely explained by the simultaneous increase of SHBG serum level. Serum SHBG is suppressed by circulating insulin, a feature of obesity or diabetes type II, which is rather common in aged men [2, 15], but this did not affect our finding of an increase of serum SHBG with aging.
Table II. Spearman’s analysi\s for the relation between androgen and aging.
Table III. The 10th and 90th percentiles for T, cFT, TSI, and FTI.
Table IV. The rate of decline for cFT, TSI, and FTI, expressed as median.
Serum T falls with aging and, as a result of the feedback mechanism, serum LH usually – but not always – rises with aging; we reasoned that the T/LH ratio in elderly men might provide insight in their gonadal status. Our data show that the decline in the value of T/LH with aging parallels closely the value of cFT. Using the T/LH ratio, there was approximately 7% underestimation in two age groups (50-59 years and 60-69 years). It merits further study as to whether the T/LH ratio is an acceptable surrogate for the cFT. In China, SHBG is not routinely measured in clinical practice, although LH is. The introduction of T/LH would be more convenient and cost effective. The FTI is the calculated value of T/SHBG, and is an indirect measure of free testosterone [3]. In our data, the FTI differed more from cFT than T/LH. With FTI there were overestimations of 3% at 40-49, 10% at 50-59, 17% at 60-69, and 25% at ≥70 years. Therefore, in the context of our study, T/LH was a better surrogate marker of cFT, and more useful than FTI in clinical practice.
Table V. The relationship between partial androgen deficiency and aging.
The present study shows a progressive increase in serum levels of SHBG, LH, FSH, and E2 in relation to aging. The increase of SHBG is likely to result from the decrease of androgen and growth hormone system (GH and IGF-1) with aging [16]. The elevations of LH and FSH are an expression of the decline in testicular function [6]. Circulating levels of E2 are mainly derived from the conversion of androgens to estrogens in peripheral tissue by aromatase [17]. As described earlier [17], we found a positive relationship between serum levels of E2 and T (r = 0.1509, p
References
1. Werner A. The male climacteric. JAMA 1939;112:1441-1443.
2. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016- 1025.
3. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-731.
4. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, van den Schouw YJ. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 2003;149:583-589.2
5. Kang YG, Bae CY, Bum MJ, Kirn S, Lee YJ, Seo J, Kim YC. Age- related change in serum concentrations of testosterone in middle- aged men. Aging Male 2003;6:8-12.
6. Jiang-Yuan L. Partial androgen deficiency in the aging male. Reprod Med (China) 2000;9:182-186.
7. Gooren LJ. Androgen levels and sex functions in testosterone- treated hypogonadal men. Arch Sex Behav 1987;6: 463-473.
8. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005;8:56-58.
9. Morales ALB. Androgen replacement therapy in aging men with secondary hypogonadism. Draft of Recommendations for Endorsement by ISSAM. Aging Male 2001;4:151-162.
10. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002;57:M76-99.
11. Vermeulen A. Androgen replacement therapy in the aging male – a critical evaluation. J Clin Endocrinol Metab 2001;86: 2380-2390.
12. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
13. Leifke E, Gorenoi V, Wichers C, von zur Muhlen A, Von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin- like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000;53:689-695.
14. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-876.
15. Schatzl G, Madersbacher S, Temml C, Krenn-Schinkel K, Mader A, Hermann M. Serum androgen levels in men: impact of health status and age. Urology 2003;61:629-633.
16. Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996;1:1821- 1826.
17. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 2002;5:98-102.
J.-Y. LI1, X.-Y. LI2, M. LI1, G.-K. ZHANG3, F.-L. MA1, Z.-M. LIU4, N.-Y. ZHANG5, & P. MENG6
1 Department of Endocrinology, PLA General Hospital, Beijing, China, 2 Department of Gerocardiology, PLA General Hospital, Beijing, China, 3 Department of Statistics, PLA General Hospital, Beijing, China, 4 Department of Endocrinology, Changzheng Hospital, Shanghai, China, 5 Department of Endocrinology, Xijing Hospital, Xian, China, and 6 Department of Endocrinology, Xinan Hospital, Chongqing, China
Correspondence: J.-Y. Li, Department of Endocrinology, PLA General Hospital, Fuxing Road, Beijing 100853, China. Tel: 86 10 6693 6222. Fax: 86 10 6816 9817. E-mail: [email protected]\
Copyright CRC Press Sep-Dec 2005
Comments